Philip Morris International Inc. Declares Regular Quarterly Dividend of $1.27 Per Share
09 März 2023 - 2:46PM
Business Wire
Regulatory News:
The Board of Directors of Philip Morris International Inc.
(NYSE: PM) today declared a regular quarterly dividend of $1.27 per
common share, payable on April 11, 2023, to shareholders of record
as of March 23, 2023. The ex-dividend date is March 22, 2023. For
more details on stock, dividends and other information, see
www.pmi.com/dividend.
Philip Morris International: Delivering a Smoke-Free
Future
Philip Morris International (PMI) is a leading international
tobacco company working to deliver a smoke-free future and evolving
its portfolio for the long term to include products outside of the
tobacco and nicotine sector. The company’s current product
portfolio primarily consists of cigarettes and smoke-free products.
Since 2008, PMI has invested more than USD 10.5 billion to develop,
scientifically substantiate and commercialize innovative smoke-free
products for adults who would otherwise continue to smoke, with the
goal of completely ending the sale of cigarettes. This includes the
building of world-class scientific assessment capabilities, notably
in the areas of pre-clinical systems toxicology, clinical and
behavioral research, as well as post-market studies. In November
2022, PMI acquired Swedish Match – a leader in oral nicotine
delivery – creating a global smoke-free champion led by the
companies’ IQOS and ZYN brands. The U.S. Food and Drug
Administration (FDA) has authorized versions of PMI’s IQOS Platform
1 devices and consumables and Swedish Match’s General snus as
Modified Risk Tobacco Products (MRTPs). As of December 31, 2022,
PMI's smoke-free products were available for sale in 73 markets,
and PMI estimates that approximately 17.8 million adults around the
world had already switched to IQOS and stopped smoking. Smoke-free
products accounted for approximately 32% of PMI’s total full-year
2022 net revenues. With a strong foundation and significant
expertise in life sciences, PMI announced in February 2021 its
ambition to expand into wellness and healthcare areas and, through
its Vectura Fertin Pharma subsidiary, aims to enhance life through
the delivery of seamless health experiences. For more information,
please visit www.pmi.com and www.pmiscience.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230308005843/en/
Investor Relations: Stamford, CT: +1 (203) 904 2410 Lausanne:
+41 (0)58 242 4666 Email: InvestorRelations@pmi.com
Media: David Fraser Lausanne: +41 (0)58 242 4500 Email:
David.Fraser@pmi.com
Philip Morris (NYSE:PM)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Philip Morris (NYSE:PM)
Historical Stock Chart
Von Apr 2023 bis Apr 2024